Literature DB >> 6287579

Precipitated withdrawal by a benzodiazepine receptor antagonist (Ro 15-1788) after 7 days of diazepam.

S E Lukas, R R Griffiths.   

Abstract

Baboons implanted with intragastric catheters were given diazepam (10 milligrams per kilogram of body weight) twice daily for 45 consecutive days. On days 7 and 35, they were given intramuscular injections of the benzodiazepine receptor antagonist Ro 15-1788. Mild and intermediate withdrawal signs, including retching and vomiting, were observed after 7 days of diazepam, and more frequent and intense withdrawal signs, including tremor and convulsion, occurred after 35 days of diazepam. With the termination of the diazepam injections after 45 days, a mild to intermediate withdrawal syndrome was observed over the next 15-day period.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6287579     DOI: 10.1126/science.6287579

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  27 in total

Review 1.  Sedation for fibreoptic bronchoscopy.

Authors:  M P Shelley; P Wilson; J Norman
Journal:  Thorax       Date:  1989-10       Impact factor: 9.139

2.  Drug Discrimination and the Analysis of Private Events.

Authors:  Brian D Kangas; David R Maguire
Journal:  Behav Anal (Wash D C)       Date:  2016-03-14

3.  A late-appearing benzodiazepine-induced hypoactivity that is not reversed by a receptor antagonist.

Authors:  R G Lister; S E File
Journal:  Psychopharmacology (Berl)       Date:  1986       Impact factor: 4.530

4.  Precipitated withdrawal in squirrel monkeys after repeated daily oral administration of alprazolam, diazepam, flunitrazepam or oxazepam.

Authors:  J R Martin; J L Moreau; F Jenck
Journal:  Psychopharmacology (Berl)       Date:  1995-04       Impact factor: 4.530

5.  Prediction and Prevention of Prescription Drug Abuse: Role of Preclinical Assessment of Substance Abuse Liability.

Authors:  Julie A Marusich; Timothy W Lefever; Scott P Novak; Bruce E Blough; Jenny L Wiley
Journal:  Methods Rep RTI Press       Date:  2013-07

6.  Effects of morphine, naloxone, buprenorphine, butorphanol, haloperidol and imipramine on morphine withdrawal signs in cynomolgus monkeys.

Authors:  H Fukase; K Fukuzaki; T Koja; R Nagata; S E Lukas
Journal:  Psychopharmacology (Berl)       Date:  1994-12       Impact factor: 4.530

7.  Oral self-administration of triazolam, diazepam and ethanol in the baboon: drug reinforcement and benzodiazepine physical dependence.

Authors:  N A Ator; R R Griffiths
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

8.  Reducing abuse liability of GABAA/benzodiazepine ligands via selective partial agonist efficacy at alpha1 and alpha2/3 subtypes.

Authors:  Nancy A Ator; John R Atack; Richard J Hargreaves; H Donald Burns; Gerard R Dawson
Journal:  J Pharmacol Exp Ther       Date:  2009-09-29       Impact factor: 4.030

9.  Flumazenil-precipitated withdrawal in healthy volunteers following repeated diazepam exposure.

Authors:  Miriam Z Mintzer; Roland R Griffiths
Journal:  Psychopharmacology (Berl)       Date:  2004-09-25       Impact factor: 4.530

10.  Role of gamma-aminobutyric acid type A (GABAA) receptor subtypes in acute benzodiazepine physical dependence-like effects: evidence from squirrel monkeys responding under a schedule of food presentation.

Authors:  Bradford D Fischer; Laura P Teixeira; Michael L van Linn; Ojas A Namjoshi; James M Cook; James K Rowlett
Journal:  Psychopharmacology (Berl)       Date:  2013-01-26       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.